"ID";"Original Title";"Title";"Summary";"Contact";"Citation";"URL Scientific Article";"More References";"Keywords";"Field of Research";"Method/Model";"Year of Publication";"Month of Publication";"Date of Editing"; "1589";"Xeno-free reprogramming of peripheral blood mononuclear erythroblasts on laminin-521";"Xeno-free reprogramming of peripheral blood mononuclear erythroblasts";"Translating human induced pluripotent stem cell (hiPSC)–derived cells and tissues into the clinic requires streamlined and reliable production of clinical-grade hiPSCs. This article describes an entirely animal component–free procedure for the reliable derivation of stable hiPSC lines from donor peripheral blood mononuclear cells (PBMCs) using only autologous patient materials and xeno-free reagents. hiPSC lines derived using this method display expression of expected surface markers and transcription factors, loss of the reprogramming agent–derived nucleic acids, genetic stability, and the ability to robustly differentiate in vitro to multiple lineages.";"Thorsten M. Schlaeger, Boston Children's Hospital, Boston, USA";"Christian Skorik et al. Current Protocols in Stem Cell Biology 2020";"https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpsc.103";"";"stem cells, blood";"Haematology, Immunology, Method development, Stem cell research";"Cell culture, Tissue models";"2020";"01";"2022-10-26 17:51:39";